Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
TELUS annonce d’excellents résultats au deuxième trimestre de 2018

2018-08-03 globenewswire
Croissance des produits d’exploitation consolidés et du BAIIA de 5,3 pour cent et de 3,6 pour cent respectivement ou, à l’exclusion des effets de la norme IFRS 15, de 5,8 pour cent et de 5 pour cent, respectivement; excellent flux de trésorerie disponible de 329 millions de dollars, en hausse de 27 pour cent par rapport à l’an dernier
T TU

0
TELUS reports strong results for second quarter 2018

2018-08-03 globenewswire
Consolidated revenue and EBITDA growth of 5.3 per cent and 3.6 per cent respectively, or 5.8 per cent and 5.0 per cent respectively, excluding IFRS 15 impact; Strong free cash flow of $329 million, up 27 per cent over last year
T MTTRY TU

0
Telus Corporation Notice of Cash Dividend

2018-08-03 globenewswire
VANCOUVER, British Columbia, Aug. 03, 2018 (GLOBE NEWSWIRE) -- NOTICE IS HEREBY GIVEN that the Board of Directors has declared a quarterly dividend of $0.525 Canadian per share on the issued and outstanding Common shares payable on October 1, 2018 to holders of record at the close of business on September 10, 2018.
T

0
Telus Corporation avis de dividende en espèces

2018-08-03 globenewswire
VANCOUVER, Colombie-Britannique, 03 août 2018 (GLOBE NEWSWIRE) -- AVIS EST PAR LES PRÉSENTES DONNÉ que le conseil d’administration a déclaré un dividende trimestriel de 0,525 $ CA par action sur les actions ordinaires émises et en circulation. Ce dividende sera versé le 1er octobre 2018 aux détenteurs inscrits à la clôture des marchés le 10 septembre 2018.
T TU

0
TELUS debuts connected security and smart home solutions for homes and small businesses

2018-07-30 globenewswire
VANCOUVER, British Columbia, July 30, 2018 (GLOBE NEWSWIRE) -- TELUS has launched TELUS SmartHome Security and TELUS Secure Business, marking its entrance to the smart home and business security market. The company’s recent acquisition of AlarmForce customers in Western Canada helped to provide the foundation for the two new offerings, which have replaced the AlarmForce brand in Western Canada. Both TELUS SmartHome Security and TELUS Secure Business are available now in B.
T TU

0
TELUS and Doctors of the World Canada bring innovative mobile outreach program Health for Good™ to marginalized communities in Victoria

2018-07-11 globenewswire
VICTORIA, British Columbia, July 11, 2018 (GLOBE NEWSWIRE) -- Today, TELUS and Doctors of the World Canada announced the launch of the innovative TELUS Health for Good™ program in Victoria. Doctors of the World, with community partners and voluntary health practitioners, will leverage the Mobile Health Clinic, powered by TELUS, to deliver primary healthcare to the city’s most vulnerable citizens. This mobile health “clinic on wheels” acts as a vital link between the community and the health authority enabling the reconnection of homeless citizens to the public health and social services network.
T VCP TU

0
REMINDER/Media Advisory: Victoria’s most vulnerable citizens get better access to healthcare with TELUS Health for Good(TM) and Doctors of the World

2018-07-11 globenewswire
VICTORIA, British Columbia, July 11, 2018 (GLOBE NEWSWIRE) -- On Wednesday, July 11, 2018, at a community event with local dignitaries, TELUS and Doctors of the World Canada will officially unveil an innovative mobile health “clinic on wheels” which aims to provide access to primary healthcare within the city’s marginalized communities. Details follow.
T TU

0
MEDIA ADVISORY - Victoria’s most vulnerable citizens get better access to healthcare with TELUS Health for GoodTM and Doctors of the World

2018-07-09 globenewswire
VICTORIA, British Columbia, July 09, 2018 (GLOBE NEWSWIRE) -- On Wednesday, July 11, 2018, at a community event with local dignitaries, TELUS and Doctors of the World Canada will officially unveil an innovative mobile health “clinic on wheels” which aims to provide access to primary healthcare within the city’s marginalized communities. Details follow.
T TU

6
Telecom Stock Roundup: Verizon Go90 Pullout, China Mobile's US Entry Block & More

2018-07-05 zacks
In the last five trading days, telecom stocks witnessed a sharp rise initially as China eased some foreign investment curbs but fell slightly thereafter to maintain a flat trajectory. The stocks regained the lost ground later in the week due to temporary relief to ZTE to resume some business activities. Amid the looming trade war tensions between the United States and China, the communist nation took a positive step toward easing the limits on foreign ownership in some of its closely guarded sectors.
HCOM DB CHLKF DLPH VZA T 0941 MSI CBB CHL VZ QCOM SBAC TU

2
TELUS investing $110 million to connect Richmond and Steveston homes and businesses directly to advanced fibre optic network

2018-06-29 globenewswire
RICHMOND, British Columbia, June 29, 2018 (GLOBE NEWSWIRE) -- TELUS is investing $110 million to connect more than 90 per cent of homes and businesses in Richmond and Steveston directly to its fibre optic network. Construction work is currently underway, and TELUS anticipates connecting the majority of homes and businesses by the spring of 2019.
T TU

2
TELUS to early redeem 5.05 per cent, Series CG Notes due December 4, 2019

2018-06-28 globenewswire
VANCOUVER, British Columbia, June 28, 2018 (GLOBE NEWSWIRE) -- TELUS announced that it has given notice today of a full redemption on August 1, 2018 of its outstanding C$1 billion 5.05 per cent Notes due December 4, 2019 (CUSIP No. 87971MAK9). The redemption price will be calculated in accordance with the applicable indenture.
T TU

77
Juicy Dividend Payers Come Under Attack - My Wide Moat 7

2018-06-25 seekingalpha - 1
Higher yielding dividend payers can come under pressure when the 'risk free' yield starts to look more attractive.
RBC TRP RCI BCEXF BMO ENB TD T BMO BCE ENB S T BNS CM TRP TU

16
TELUS conclut avec succès son émission obligataire en dollars US

2018-06-12 globenewswire
VANCOUVER, Colombie-Britannique, 12 juin 2018 (GLOBE NEWSWIRE) -- TELUS a annoncé aujourd’hui qu’elle a conclu avec succès l’émission de 750 millions de dollars US de billets non garantis de premier rang d’une échéance de 30 ans, à un taux d’intérêt de 4,60 pour cent, arrivant à échéance le 16 novembre 2048 (les « billets »).
T AOS TU

16
TELUS successfully closes US debt offering

2018-06-12 globenewswire
VANCOUVER, British Columbia, June 12, 2018 (GLOBE NEWSWIRE) -- TELUS announced today it has successfully closed its previously announced offering of US$750 million of senior unsecured 4.60 per cent 30-year notes, maturing on November 16, 2048 (the “notes”).
T AOS TU

16
TELUS fixe le prix de son émission obligatoire en dollars US

2018-06-08 globenewswire
VANCOUVER, Colombie-Britannique, 07 juin 2018 (GLOBE NEWSWIRE) -- TELUS a annoncé aujourd’hui une émission de 750 millions de dollars US de billets non garantis de premier rang d’une échéance de 30 ans (les « billets »). Les billets sont émis par l’intermédiaire d’un syndicat de preneurs fermes dirigé par Merrill Lynch, Pierce, Fenner & Smith Incorporated, RBC Marchés des Capitaux, TD Securities (USA) LLC et Wells Fargo Securities, LLC.
T AOS TU

Related Articles

REPH: Recro Pharma Analysis and Research Report

2018-08-20 - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

2018-08-20 - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2018-08-20 - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...